|
PART I Structural and Molecular Bases of Ion Channel Function |
|
|
|
1 Voltage-Gated Sodium Channels and Electrical Excitability of the Heart |
|
|
1 | (13) |
|
|
|
|
|
2 Voltage-Gated Calcium Channels |
|
|
14 | (17) |
|
|
|
|
|
3 Voltage-Regulated Potassium Channels |
|
|
31 | (10) |
|
|
|
4 Molecular Regulation of Cardiac Inward Rectifier Potassium Channels |
|
|
41 | (9) |
|
|
|
5 Mammalian Calcium Pumps in Health and Disease |
|
|
50 | (13) |
|
|
|
|
|
6 Structural and Molecular Bases of Sarcoplasmic Reticulum Ion Channel Function |
|
|
63 | (7) |
|
|
|
|
|
|
|
7 Organellar Ion Channels and Transporters |
|
|
70 | (15) |
|
|
|
|
|
|
|
|
|
8 Gap Junctional Connexin43: Novel Insights from the New Millennium and Their Clinical Implications |
|
|
85 | (18) |
|
|
|
|
|
|
|
PART II Biophysics of Cardiac Ion Channel Function |
|
|
|
9 Computational Modeling and Simulation for Human Cardiac Electrophysiology: From Induced Pluripotent Stem Cell-Derived Cardiomyocytes to Adult Cardiomyocytes |
|
|
103 | (10) |
|
|
|
|
|
10 Regulation of Cardiac Calcium Channels |
|
|
113 | (11) |
|
|
|
11 Molecular Genetics of ATP-Sensitive Potassium Channels in Cardiovascular Diseases |
|
|
124 | (14) |
|
|
|
12 Role of Enhancers in Transcriptional Regulation of Cardiac Electrical Activity |
|
|
138 | (5) |
|
|
|
|
|
13 Functional Characterization of Ion Channel Gene Variants in Sudden Unexplained Natural Death |
|
|
143 | (12) |
|
|
|
|
|
|
|
14 Stretch-Activated Potassium Channels in the Human Heart: Pathophysiologic and Clinical Significance |
|
|
155 | (13) |
|
|
|
|
|
15 Connexins and Pannexins in Cardiovascular Disease |
|
|
168 | (10) |
|
|
|
|
|
16 Excitation-Contraction Coupling |
|
|
178 | (10) |
|
|
|
PART III Intermolecular Interactions and Cardiomyocyte Electrical Function |
|
|
|
17 Ion Channel Trafficking in the Heart |
|
|
188 | (22) |
|
|
|
18 Microdomain Interactions of Macromolecular Complexes and Regulation of the Sodium Channel Nav1.5 |
|
|
196 | (14) |
|
|
|
|
|
19 Connecting Cardiac Excitation to the Atomic Interactions of Ion Channels |
|
|
210 | (8) |
|
|
|
|
|
|
|
20 Macromolecular Complexes and Cardiac Potassium Channels |
|
|
218 | (10) |
|
|
|
|
|
21 Reciprocity of Cardiac Sodium and Potassium Channels in the Control of Excitability and Arrhythmias |
|
|
228 | (15) |
|
|
|
|
|
22 The Intercalated Disc: A Molecular Network That Integrates Electrical Coupling, Intercellular Adhesion, and Cell Excitability |
|
|
243 | (15) |
|
Chantal J.M. van Opbergen |
|
|
|
|
|
|
|
|
23 Function and Dysfunction of Ion Channel Membrane Trafficking and Posttranslational Modification |
|
|
258 | (8) |
|
|
|
|
|
|
|
24 Feedback Mechanisms for Cardiac-Specific microRNAs and cAMP Signaling in Electrical Remodeling |
|
|
266 | (10) |
|
|
|
|
|
|
|
PART IV Cell Biology of Cardiac Impulse Initiation and Propagation |
|
|
|
25 Coupled Oscillators and Sinoatrial Pacemaker Activity |
|
|
276 | (15) |
|
|
|
|
|
26 Mapping of Cardiac Action Potentials in Zebrafish to Assess Genetic Variants |
|
|
291 | (11) |
|
|
|
|
|
|
|
21 Cell-To-Cell Communication and Impulse Propagation |
|
|
302 | (14) |
|
|
|
28 Mechanisms of Normal and Dysfunctional Sinoatrial Nodal Excitability and Propagation |
|
|
316 | (14) |
|
|
|
|
|
|
|
29 Cell Biology of the Specialized Cardiac Conduction System |
|
|
330 | (14) |
|
|
|
|
|
PART V Models of Cardiac Excitation |
|
|
|
30 Computational Prediction of Drug-Induced Arrhythmias |
|
|
344 | (7) |
|
|
|
31 Global Optimization Approaches to Generate Dynamically Robust Electrophysiologic Models |
|
|
351 | (11) |
|
|
|
|
|
32 Calcium Signaling in Cardiomyocyte Models With Realistic Geometries |
|
|
362 | (14) |
|
|
|
|
|
|
|
33 Theory of Rotors and Arrhythmias |
|
|
376 | (11) |
|
|
|
|
|
34 Distinct ECG Phenotypes Identified in Hypertrophic Cardiomyopathy Using Machine Learning Associated With Arrhythmic Risk Markers |
|
|
387 | (17) |
|
|
|
|
|
|
|
35 Computational Approaches for Accurate Rotor Localization in the Atria |
|
|
404 | (14) |
|
|
|
36 Modeling the Aging Heart |
|
|
418 | (12) |
|
|
|
|
|
37 Electromechanic Imaging of the Heart |
|
|
430 | (14) |
|
|
|
Johannes Schroder-Schetelig |
|
|
|
|
|
|
PART VI Neural Control of Cardiac Electrical Activity |
|
|
|
38 Innervation of the Sinoatrial Node |
|
|
444 | (8) |
|
|
|
Kristina Rysevaite-Kyguoliene |
|
|
|
|
39 Autonomic and Oxidant Regulation of Cardiac Sodium Currents: Mechanisms and Consequences |
|
|
452 | (9) |
|
|
|
40 Neural Activity and Atrial Tachyarrhythmias |
|
|
461 | (12) |
|
|
|
|
|
|
|
|
|
|
|
|
|
41 Sympathetic Modulation of Cardiac Electrophysiology |
|
|
473 | (8) |
|
|
|
|
|
42 Role of the Autonomic Nervous System in Atrial Fibrillation |
|
|
481 | (8) |
|
|
|
|
|
|
|
PART VII Arrhythmia Mechanisms |
|
|
|
43 Rotational and Focal Sources of Atrial Fibrillation: Scientific Rationale and Comparative Clinical Mapping |
|
|
489 | (16) |
|
|
|
|
|
|
|
44 Noninvasive Frequency-Phase Mapping of Atrial Fibrillation |
|
|
505 | (8) |
|
|
|
|
|
|
|
|
|
45 Mechanistic Approaches for Persistent Atrial Fibrillation Ablation |
|
|
513 | (16) |
|
|
|
|
|
46 Mechanisms of Human Ventricular Tachycardia and Human Ventricular Fibrillation |
|
|
529 | (17) |
|
|
|
|
|
47 Genetics of Atrial Fibrillation |
|
|
546 | (8) |
|
|
|
|
|
PART VIII Molecular Genetics and Pharmacogenomics |
|
|
|
48 Mechanisms in Genetic Sodium Channel Diseases |
|
|
554 | (11) |
|
|
|
|
|
49 Genetic, Ionic, and Cellular Mechanisms Underlying the J Wave Syndromes |
|
|
565 | (18) |
|
|
|
|
|
50 Inheritable Potassium Channel Diseases |
|
|
583 | (11) |
|
|
|
|
|
51 Inheritable Phenotypes Associated With Altered Intracellular Calcium Regulation |
|
|
594 | (10) |
|
|
|
|
|
PART IX Pharmacologic, Genetic, and Cell Therapy of Ion Channel Dysfunction |
|
|
|
52 Dominant Frequency as a Tool for Personalized Monitoring of Atrial Fibrillation Progression and Upstream Therapy |
|
|
604 | (11) |
|
|
|
53 Pharmacogenomics of Cardiac Arrhythmias |
|
|
615 | (7) |
|
|
|
54 Deep Phenotyping: Adding New Tools to Understand Disease |
|
|
622 | (9) |
|
|
|
|
|
55 Gene Therapy for Atrial Fibrillation |
|
|
631 | (14) |
|
|
|
|
|
|
|
PART X Cell Biology and Electrophysiology of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes |
|
|
|
56 Cardiac Remodeling and Regeneration |
|
|
645 | (9) |
|
|
|
|
|
57 High-Throughput Optical Mapping of Two-Dimensional hiPSC-CM Platforms for Drug Discovery and Cardiotoxicity Testing |
|
|
654 | (17) |
|
|
|
58 Functional Cardiac Fibroblasts Derived From Human Pluripotent Stem Cells via Second Heart Field Progenitors |
|
|
671 | (9) |
|
|
|
|
|
59 Challenges of Human iPSC-CM Technology: Increasingly Complex Approaches Improve Cell Maturation and Relevance to Modeling Human Cardiac Disease |
|
|
680 | (13) |
|
Maria Linarejos Vera Pedrosa |
|
|
|
|
PART XI Diagnostic Evaluation |
|
|
|
60 Assessment of the Patient With a Cardiac Arrhythmia |
|
|
693 | (7) |
|
|
|
|
|
61 Differential Diagnosis of Narrow and Wide Complex Tachycardias |
|
|
700 | (8) |
|
|
|
|
|
62 Electrocardiographic Monitoring: Short- and Long-Term Recording |
|
|
708 | (8) |
|
|
|
|
|
|
|
|
|
63 Personal Cardiac Monitoring |
|
|
716 | (12) |
|
|
|
|
|
|
|
64 Computed Tomography for Electrophysiology |
|
|
728 | (16) |
|
Alejandro Jimenez Restrepo |
|
|
|
|
65 Magnetic Resonance Imaging for Electrophysiology |
|
|
744 | (12) |
|
|
|
|
|
|
|
66 Intracardiac Echocardiography for Electrophysiology |
|
|
756 | (8) |
|
|
|
|
|
67 Autonomic Nervous System Assessment for Syncope and Arrhythmia Risk |
|
|
764 | (9) |
|
|
|
|
|
|
|
68 Noninvasive Electrocardiographic Imaging of Arrhythmogenic Substrates and Ventricular Arrhythmias |
|
|
773 | (13) |
|
|
|
|
|
786 | (6) |
|
|
|
|
|
PART XII Supraventricular Arrhythmias: Diagnosis and Therapy |
|
|
|
70 Supraventricular Tachycardias: Diagnostic Maneuvers in the Electrophysiology Laboratory |
|
|
792 | (14) |
|
|
|
|
|
|
|
|
|
806 | (23) |
|
|
|
|
|
72 Atrioventricular Nodal Reentrant Tachycardia |
|
|
829 | (24) |
|
|
|
|
|
|
|
|
|
|
|
73 Junctional Tachycardia |
|
|
853 | (8) |
|
|
|
|
|
|
|
|
|
74 Preexcitation, Atrioventricular Reentry, Variants |
|
|
861 | (15) |
|
|
|
75 Atrial Fibrillation: Mechanisms, Clinical Features, and Management |
|
|
876 | (15) |
|
|
|
|
|
|
|
76 Ablation for Atrial Fibrillation |
|
|
891 | (11) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
77 Left Atrial Appendage Management: Anatomy, Physiology, and Role in Atrial Fibrillation---Related Stroke |
|
|
902 | (9) |
|
|
|
|
|
78 Typical and Atypical Atrial Flutter: Mapping and Ablation |
|
|
911 | (14) |
|
|
|
|
|
|
|
|
|
PART XIII Ventricular Arrhythmias |
|
|
|
79 Sudden Cardiac Death in Adults |
|
|
925 | (13) |
|
|
|
|
|
80 Premature Ventricular Complexes |
|
|
938 | (9) |
|
|
|
|
|
81 Outflow Tract Ventricular Tachyarrhythmias: Mechanisms, Clinical Features, and Management |
|
|
947 | (13) |
|
|
|
|
|
82 Premature Ventricular Contraction Ablation With Anatomic Guidance: Papillary Muscles, Moderator Band, and Valve Annulus Sites |
|
|
960 | (10) |
|
|
|
|
|
83 Fascicular Ventricular Arrhythmias |
|
|
970 | (7) |
|
|
|
|
|
84 Bundle Branch Reentry Tachycardia |
|
|
977 | (15) |
|
|
|
|
|
85 Ischemic Heart Disease |
|
|
992 | (9) |
|
|
|
|
|
|
|
86 Ablation of Postmyocardial Infarction Ventricular Tachycardia |
|
|
1001 | (13) |
|
|
|
|
|
|
|
|
|
87 Ventricular Tachycardia in Patients With Dilated Cardiomyopathy |
|
|
1014 | (14) |
|
|
|
|
|
88 Lamin A/C, Noncompaction, and Other Genetic Cardiomyopathies With Ventricular Arrhythmias |
|
|
1028 | (10) |
|
|
|
|
|
|
|
89 Ventricular Tachyarrhythmias in Hypertrophic Cardiomyopathy: Sudden Death, Risk Stratification, and Prevention With Implantable Defibrillators |
|
|
1038 | (12) |
|
|
|
|
|
|
|
90 Ventricular Tachycardias in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy |
|
|
1050 | (11) |
|
|
|
|
|
91 Catecholaminergic Polymorphic Ventricular Tachycardia |
|
|
1061 | (12) |
|
|
|
|
|
92 Arrhythmias and Conduction Disturbances in Noncompaction Cardiomyopathy |
|
|
1073 | (10) |
|
|
|
|
|
|
|
93 Ventricular Arrhythmias in Takotsubo Cardiomyopathy |
|
|
1083 | (6) |
|
|
|
|
|
94 Mitral Valve Prolapse, Ventricular Arrhythmias, and Sudden Death |
|
|
1089 | (11) |
|
|
|
|
|
|
|
|
|
|
|
1100 | (11) |
|
|
|
96 Long and Short QT Syndromes |
|
|
1111 | (18) |
|
|
|
|
|
|
|
97 Andersen-Tawil Syndrome |
|
|
1129 | (7) |
|
|
|
|
|
|
|
1136 | (10) |
|
|
|
|
|
|
|
|
|
|
|
1146 | (11) |
|
|
|
|
|
|
|
100 Idiopathic and Short-Coupled Ventricular Fibrillation |
|
|
1157 | (9) |
|
|
|
|
|
|
|
101 Mapping and Ablation of Ventricular Fibrillation |
|
|
1166 | (12) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
102 Drug-Induced Ventricular Arrhythmias |
|
|
1178 | (11) |
|
|
|
|
|
PART XIV Syncope and Bradyarrhythmias |
|
|
|
|
|
1189 | (8) |
|
|
|
|
|
|
|
104 Sinus Node Abnormalities |
|
|
1197 | (6) |
|
|
|
|
|
|
|
105 Postural Orthostatic Tachycardia Syndrome |
|
|
1203 | (6) |
|
|
|
|
|
106 Atrioventricular Block |
|
|
1209 | (9) |
|
|
|
PART XV Arrhythmias in Special Populations |
|
|
|
107 Sex Differences in Arrhythmias |
|
|
1218 | (8) |
|
|
|
|
|
108 Sudden Cardiac Deaths in Athletes, Including Commotio Cordis |
|
|
1226 | (14) |
|
|
|
|
|
|
|
1240 | (8) |
|
|
|
|
|
|
|
110 Sleep-Disordered Breathing and Arrhythmias |
|
|
1248 | (9) |
|
|
|
|
|
|
|
111 Ventricular Assist Devices and Cardiac Transplant Recipients |
|
|
1257 | (12) |
|
|
|
|
|
|
|
|
|
|
|
|
|
112 Arrhythmia in Neurologic Disease |
|
|
1269 | (17) |
|
|
|
|
|
113 Cancer Therapy-Related Arrhythmias |
|
|
1286 | (10) |
|
|
|
|
|
PART XVI Congenital Heart Disease and Pediatrics |
|
|
|
114 Arrhythmias in the Pediatric Population |
|
|
1296 | (18) |
|
|
|
115 Supraventricular Tachycardias in Congenital Heart Disease |
|
|
1314 | (16) |
|
|
|
|
|
116 Ventricular Arrhythmias in Congenital Heart Disease |
|
|
1330 | (17) |
|
|
|
|
|
|
|
PART XVII Pharmacologic Therapy |
|
|
|
|
|
1347 | (15) |
|
|
|
|
|
|
|
118 Impact of Nontraditional Antiarrhythmic Drugs on Sudden Cardiac Death |
|
|
1362 | (9) |
|
|
|
|
|
|
|
119 Anticoagulation for Thromboembolic Prophylaxis |
|
|
1371 | (12) |
|
|
|
|
|
PART XVIII Devices for Arrhythmia Management |
|
|
|
120 Implantable Pacemakers |
|
|
1383 | (12) |
|
|
|
121 Implantable Cardioverter-Defibrillators: Technical Aspects |
|
|
1395 | (14) |
|
|
|
|
|
122 Transvenous Implantable Cardioverter-Defibrillator: Clinical Aspects |
|
|
1409 | (18) |
|
|
|
|
|
123 Subcutaneous Implantable Cardioverter-Defibrillators |
|
|
1427 | (11) |
|
|
|
|
|
124 Wearable Defibrillators |
|
|
1438 | (7) |
|
|
|
|
|
|
|
125 Cardiac Resynchronization |
|
|
1445 | (17) |
|
|
|
|
|
126 Management of Implanted Device Infections |
|
|
1462 | (9) |
|
|
|
|
|
PART XIX Catheter and Surgical Mapping and Ablation |
|
|
|
127 Electrogram Recording and Signal Processing |
|
|
1471 | (15) |
|
|
|
|
|
|
|
128 Electroanatomic Mapping for Arrhythmias |
|
|
1486 | (17) |
|
|
|
|
|
|
|
129 Mapping Scar-Related Arrhythmias |
|
|
1503 | (13) |
|
|
|
|
|
130 Radiofrequency Ablation |
|
|
1516 | (15) |
|
|
|
|
|
131 Cryoablation and Other Radiofrequency Alternatives |
|
|
1531 | (12) |
|
|
|
|
|
132 Transvascular Ethanol Ablation |
|
|
1543 | (14) |
|
|
|
|
|
133 Cardiac Radioablation |
|
|
1557 | (9) |
|
|
|
|
|
134 Epicardial Approach in Electrophysiology |
|
|
1566 | (15) |
|
|
|
|
|
|
|
|
|
|
|
135 Surgery for Atrial Fibrillation and Other Supraventricular Tachycardias |
|
|
1581 | (17) |
|
|
|
|
|
|
|
|
|
136 Surgery for Ventricular Arrhythmias |
|
|
1598 | (11) |
|
|
|
|
|
137 Neuromodulation for the Treatment of Arrhythmias |
|
|
1609 | (12) |
|
|
|
|
|
|
|
|
|
PART XX Drug Discovery for Cardiac Arrhythmias |
|
|
|
138 Drug Discovery for Myocardial Diseases and Cardiac Arrhythmias Using Zebrafish |
|
|
1621 | |
|
|
|
|
Lisainfo e-raamatute kohta